* U.S. Food and drug administration (FDA) has approved
gadavist (gadobutrol) injection for use with magnetic resonance
angiography (mra) to evaluate known or suspected supra-aortic or
renal artery disease in adult and pediatric patients
Further company coverage:
(Frankfurt Newsroom)
Read more
No comments:
Post a Comment